| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |